关于与癌症治疗相关的肺损伤的专家共识
Xinqing Lin1, Hui Guo2, Wei Zhao3
1State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Journal of thoracic disease
|May 22, 2025
概括
与癌症治疗相关的肺损伤 (CTLI) 是癌症疗法的严重副作用. 这一共识为诊断和管理CTLI提供了指导方针,强调为更好的患者结果提供多学科护理.
科学领域:
- 肺部医学 肺部医学
- 在瘤学瘤学.
- 关键的护理关键的护理
背景情况:
- 癌症治疗可以导致急性或慢性肺损伤 (CTLI),呈现出各种临床表现.
- 缺乏特定的诊断方案可能会导致病情迅速恶化和危及生命的情况.
- 对于CTLI诊断和管理,没有普遍接受的共识.
研究的目的:
- 为诊断和管理与癌症治疗相关的肺损伤 (CTLI) 建立共识文件.
- 通过全面的指导方针提高临床医生的认识和标准化治疗实践.
- 引入CTLI的结构化管理框架.
主要方法:
- 召开了一个多学科专家小组.
- 进行了系统的文献审查和详细的小组讨论.
- 制定了9个关键建议.
主要成果:
- 该共识文件涵盖了CTLI概念,流行病学,病因,风险因素,诊断和管理.
- 提供了详细的诊断协议和结构化的管理框架 (分级,类型,分期).
- 重点是提高认识和标准化治疗实践.
结论:
- 该共识为CTLI提供了详细的诊断协议和管理框架.
- 强调多学科团队 (MDT) 合作的关键作用.
- 强调个性化,全过程的患者护理策略,以优化临床结果.
相关概念视频
Other Pulmonary Disorders
790
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
790
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


